Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Suzuken Co ( (JP:9987) ) is now available.
Suzuken’s board has approved a two-for-one stock split of its common shares, effective October 1, 2026, with September 30, 2026 set as the record date. The move will double the number of shares outstanding to 144,334,408, while leaving authorized share capital and paid-in capital unchanged.
The split is aimed at lowering the minimum investment threshold and widening access to the stock, which the company expects will enhance liquidity and broaden its investor base. Year-end dividends for the fiscal year ending March 31, 2027 will be calculated on the post-split share count, with guidance implying an effective dividend increase versus the prior fiscal year when viewed on a pre-split basis.
The most recent analyst rating on (JP:9987) stock is a Buy with a Yen7100.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. is a Japanese company listed on the Prime Market of the Tokyo and Nagoya stock exchanges and the Sapporo Securities Exchange under stock code 9987. Operating in the healthcare and pharmaceutical distribution sector, it focuses on supplying medical-related products and services to a broad customer base in Japan.
Average Trading Volume: 196,968
Technical Sentiment Signal: Buy
Current Market Cap: Yen301.6B
For a thorough assessment of 9987 stock, go to TipRanks’ Stock Analysis page.